4.6 Article

STING Ligand-Mediated Priming of Functional CD8+ T Cells Specific for HIV-1-Protective Epitopes from Naive T Cells

期刊

JOURNAL OF VIROLOGY
卷 95, 期 16, 页码 -

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.00699-21

关键词

CD8(+) T cells; HIV-1; HLA; STING ligand; conserved regions; naive T cells; protective epitope

类别

资金

  1. Japan Agency for Medical Research and Development (AMED) [18fk0410021h0001, 19fk0410021h0002, 20fk0410021h0003, 21fk0410044h0001]
  2. Japan Society for the Promotion of Science (JSPS) KAKENHI [20H03726, 20K07549]
  3. Imai Memorial Trust for AIDS Research
  4. Grants-in-Aid for Scientific Research [20K07549, 20H03726] Funding Source: KAKEN

向作者/读者索取更多资源

The study demonstrated that priming with STING ligand 3'3'-cGAMP effectively activated HLA-B*52:01-restricted CD8(+) T cells, which showed strong ability to suppress HIV-1 replication and expressed high levels of cytolytic effector molecules. This suggests that priming with STING ligand of functional CD8(+) T cells specific for protective epitopes could be beneficial in an HIV-1 cure therapy.
Functional HIV-1-specific CD8(+) T cells primed from naive T cells are expected to act as effector T cells in a shock-and-kill therapeutic strategy for an HIV-1 cure since less functional HIV-1-specific CD8(+) T cells are elicited from memory T cells in HIV-1-infected individuals on combined antiretroviral therapy (cART). CD8(+) T cells specific for HIV-1 conserved and protective epitopes are candidates for such T cells. We investigated the priming with STING ligand of CD8(+) T cells specific for HLA-B*52:01 or HLA-C*12:02-restricted protective epitopes from naive T cells. STING ligand 3'3'-cGAMP effectively primed CD8(+) T cells specific for 3 of 4 HLA-B*52:01-restricted epitopes but failed to prime those specific for all 3 HLA-C*12:02-restricted epitopes from the naive T cells of HIV-1-uninfected individuals having an HLA-B*52:01-C*12:02 protective haplotype. These HLA-B*52:01-restricted CD8(+) T cells had a strong ability to suppress HIV-1 replication and expressed a high level of cytolytic effector molecules. The viral suppression ability of these T cells was signifi- cantly correlated with the expression level of perforin and showed a trend for a positive correlation with the expression level of CD107a. The present study highlighted the priming with STING ligand of functional CD8(+) T cells specific for protective epitopes, which T cells would contribute as effector T cells to a shock-and-kill therapy. IMPORTANCE The current shock-and-kill therapeutic strategy for HIV cure has been directed toward eliminating latent viral reservoirs by reactivation of latent reservoirs with latency-reversing agents followed by eradication of these cells by immune -mediated responses. Although HIV-1-specific T cells are expected to eradicate viral reservoirs, the function of these T cells is reduced in HIV-1-infected individuals with long-term cART. Therefore, priming of HIV-1-specific T cells with high function from naive T cells is to be expected in these individuals. In this study, we demonstrated the priming with STING ligand 3'3'-cGAMP of CD8(+) T cells specific for HIV-1-protective epitopes from naive T cells. cGAMP primed CD8(+) T cells specific for 3 HLA-B*52:01-restricted protective epitopes, which cells expressed a high level of cytolytic effector molecules and effectively suppressed HIV-1 replication. The present study suggested that the priming with STING ligand of functional CD8(+) T cells specific for protective epitopes would be useful in a therapy for an HIV-1 cure.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据